[免疫疗法治疗侵袭性垂体瘤和癌症]
Victoria A Ruiz1, Mariela Glerean1
1Servicio de Endocrinología, Metabolismo y Medicina Nuclear, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Medicina
|October 18, 2025
概括
免疫检查点抑制剂 (ICI) 在标准化疗失败后为侵袭性垂体瘤 (APT) 和垂体癌瘤 (PC) 提供了有前途的新治疗方法. 需要进一步的研究来了解它们的有效性,并确定患者反应的预测因素.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 由于侵袭性行为和高复发率,侵袭性垂体瘤 (APT) 和垂体癌 (PC) 的预后不佳.
- 泰莫佐洛米德 (TMZ) 是第一线化疗,但治疗失败需要新的治疗策略.
- 这些罕见的瘤在内分泌学中存在重大挑战,原因是瘤生长和激素分泌的潜在并发症.
研究的目的:
- 审查和分析免疫疗法,特别是免疫检查点抑制剂 (ICI) 在治疗侵袭性垂体瘤 (APT) 和垂体癌瘤 (PCs) 中的作用.
- 在这种情况下,评估ICI的疗效,作用机制,临床证据和与ICI相关的挑战.
- 确定预测APT和PC患者对免疫疗法的更好反应的潜在因素.
主要方法:
- 文献综述和对针对侵袭性垂体瘤和垂体癌的免疫治疗现有研究的分析.
- 评估临床证据,包括案例研究和新出现的试验数据.
- 瘤微环境 (TME) 的探索及其对ICI疗效的影响.
主要成果:
- 免疫检查点抑制剂 (ICI) 已成为一种有前途的治疗选择,用于在特莫索洛米德 (TMZ) 失败后的侵袭性垂体瘤 (APT) 和垂体癌 (PC) .
- 2018年报告了首个ICI使用成功案例,突出了其潜力.
- 了解瘤微环境 (TME) 对于开发创新的免疫治疗策略至关重要.
结论:
- 免疫检查点抑制剂 (ICI) 代表了一种新且充满希望的治疗策略,用于侵袭性垂体瘤 (APT) 和垂体癌 (PC).
- 对它们的疗效,机制和预测生物标志物的进一步研究是有必要的.
- 免疫疗法为管理这些罕见且具有挑战性的神经内分泌瘤提供了新的视角.
更多相关视频
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.4K
07:43Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
19.5K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Vaccines
952
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
952
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
